Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sigyn Therapeutics has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This 1 action is assigned to 1 distinct examiner and 1 distinct art unit. This indicates a highly focused prosecution profile, with all current active matters residing within a single technical specialty at the patent office. This concentration allows for a specialized approach but also means the company's immediate patent success is tied to a narrow administrative channel within the medical device department.
The busiest examiner for this portfolio is LEVY, BRANDON WILLIAM, who is responsible for 1 pending office action. Since there is only 1 pending action in total, this examiner manages the entire active portfolio. For practitioners, this means that the immediate success of the company's patent efforts is tied to the specific examination practices of this 1 examiner and the standards of the 1 art unit. Success in this matter will require a deep understanding of the specific examination style and previous rulings associated with this 1 official, as there are no other active matters to provide alternative paths to allowance. The strategy must be precisely aligned with the examiner's historical preferences to ensure a successful result for the company's medical technology.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEVY, BRANDON WILLIAM | 1 | 62.7% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 3781 | §103§112 | Non-Final OA | 61d | Pending | Sep 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial